Name: Recombinant Anti-CD2 x Anti-CD4 Bispecific Antibody (Fv-IgG)
SKU: BSDG-193
Rating: 5 (1 reviews)

Recombinant Anti-CD2 x Anti-CD4 Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-CD2 IgG with similar domains from an anti-CD4 antibody via short peptide linkers, or vice versa. This BsAb can block two antigens simultaneously. It is designed for the research of HIV-1 infection, AIDS therapy.

Datasheet INQUIRY

Specifications

Targets

CD2 & CD4

Type

Fv-IgG

Species Reactivity

Human

Application

FuncS; Promising therapeutic agent

Related Disease

HIV-1 infection, AIDS

Host Animal 1

Mouse

Host Animal 2

Mouse

Targets

Target 1

CD2

Gene ID

914

UniProt ID

P06729

Alternative Names

CD2; CD2 molecule; T11; SRBC; LFA-2; T-cell surface antigen CD2; leukocyte function-associated antigen-2; LFA-3 receptor; rosette receptor; erythrocyte receptor; lymphocyte-function antigen-2; T-cell surface antigen T11/Leu-5; CD2 antigen (p50), sheep red blood cell receptor

Target 2

CD4

Gene ID

920

UniProt ID

B4DT49

Alternative Names

CD4; CD4 molecule; CD4mut; T-cell surface glycoprotein CD4; CD4 receptor; CD4 antigen (p55); T-cell surface antigen T4/Leu-3

Our products and services are for research use only, and not for use in diagnostic or therapeutic procedures.

Online Inquiry

Customer Reviews and Q&As

There are currently no customer reviews or questions for Recombinant Anti-CD2 x Anti-CD4 Bispecific Antibody (Fv-IgG) (BSDG-193). Click the button below to contact us or submit your feedback about this product.

Recombinant Anti-CD2 x Anti-CD4 Bispecific Antibody (Fv-IgG) (CAT#: BSDG-193)

Specifications

Targets

Customer Reviews and Q&As